Paper41569167
From Radiation to Immune Response: A Systematic Review of Systemic Immunomodulation in Squamous Cell Head and Neck Cancer.
Valente Ferreira DA and 10 others. Asian Pac J Cancer Prev, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. From Radiation to Immune Response: A Systematic Review of Systemic Immunomodulation in Squamous Cell Head and Neck Cancer. Papers, record 41569167. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41569167
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- From Radiation to Immune Response: A Systematic Review of Systemic Immunomodulation in Squamous Cell Head and Neck Cancer.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Head and Neck Neoplasms | Major topic |
| Squamous Cell Carcinoma of Head and Neck | Major topic |
| Immunomodulation | Major topic |
| Humans | |
| Prognosis |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29204520 | Comprehensive assessment of circulating immune cell populations in response to stereotactic body radiation therapy in patients with liver cancer. | Adv Radiat Oncol | 2017 | https://conductscience.org/library/papers/29204520 | PubMed |
| 2 | 28344877 | Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/28344877 | PubMed |
| 3 | 28420863 | Changes in systemic immune response after stereotactic ablative radiotherapy. Preliminary results of a prospective study in patients with early lung cancer. | Pol Arch Intern Med | 2017 | https://conductscience.org/library/papers/28420863 | PubMed |
| 4 | 27380136 | Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer. | Br J Cancer | 2016 | https://conductscience.org/library/papers/27380136 | PubMed |
| 5 | 32381293 | The Impact of Radiation Therapy on Innate and Adaptive Tumor Immunity. | Semin Radiat Oncol | 2020 | https://conductscience.org/library/papers/32381293 | PubMed |
| 6 | 24097865 | Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/24097865 | PubMed |
| 7 | 30205124 | Prospective Immunophenotyping of CD8+ T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT. | Int J Radiat Oncol Biol Phys | 2019 | https://conductscience.org/library/papers/30205124 | PubMed |
| 8 | 40547025 | Advances and challenges in immunotherapy in head and neck cancer. | Front Immunol | 2025 | https://conductscience.org/library/papers/40547025 | PubMed |
| 9 | 28500490 | Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients. | Strahlenther Onkol | 2017 | https://conductscience.org/library/papers/28500490 | PubMed |
| 10 | 22682747 | Circulating regulatory T cells of cancer patients receiving radiochemotherapy may be useful to individualize cancer treatment. | Radiother Oncol | 2012 | https://conductscience.org/library/papers/22682747 | PubMed |
| 11 | 40104738 | Prognostic significance of alterations in peripheral cellular and humoral immune biomarkers during radiochemotherapy in head and neck cancer patients. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/40104738 | PubMed |
| 12 | 33336372 | Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC). | Int J Cancer | 2021 | https://conductscience.org/library/papers/33336372 | PubMed |
| 13 | 24912482 | Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck. | Radiat Oncol | 2014 | https://conductscience.org/library/papers/24912482 | PubMed |
| 14 | 27669501 | CD8+ T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancer. | Eur J Cancer | 2016 | https://conductscience.org/library/papers/27669501 | PubMed |
| 15 | 26873647 | Systemic mechanisms and effects of ionizing radiation: A new 'old' paradigm of how the bystanders and distant can become the players. | Semin Cancer Biol | 2016 | https://conductscience.org/library/papers/26873647 | PubMed |
| 16 | 30393582 | Impact of curative radiotherapy on the immune status of patients with localized prostate cancer. | Oncoimmunology | 2018 | https://conductscience.org/library/papers/30393582 | PubMed |
| 17 | 38609887 | Partial recovery of peripheral blood monocyte subsets in head and neck squamous cell carcinoma patients upon radio(chemo)therapy is associated with decreased plasma CXCL11. | BMC Cancer | 2024 | https://conductscience.org/library/papers/38609887 | PubMed |
| 18 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 19 | 31519601 | The Influence of Adjuvant Radiotherapy and Single Nucleotide Polymorphisms on Circulating Immune Response Cell Numbers and Phenotypes of Patients With Breast Cancer. | Anticancer Res | 2019 | https://conductscience.org/library/papers/31519601 | PubMed |
| 20 | 38938577 | Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients. | Front Immunol | 2024 | https://conductscience.org/library/papers/38938577 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CD69 | 969 | PubTator's text mining | https://conductscience.org/library/genes/969 | NCBI Gene |
| CTLA4 | 1493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| CX3CR1 | 1524 | PubTator's text mining | https://conductscience.org/library/genes/1524 | NCBI Gene |
| FDXR | 2232 | PubTator's text mining | https://conductscience.org/library/genes/2232 | NCBI Gene |
| GADD45A | 1647 | PubTator's text mining | https://conductscience.org/library/genes/1647 | NCBI Gene |
| ITGAL | 3683 | PubTator's text mining | https://conductscience.org/library/genes/3683 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41569167
GET https://conductscience.org/api/papers/v1/41569167/references?page=2